US 12,449,421 B1
Anti-CD79B protein monoclonal antibody, products containing the same, and uses thereof
Tongyu Lin, Chengdu (CN); Yang Liu, Chengdu (CN); Zongyao Huang, Chengdu (CN); Huangming Hong, Chengdu (CN); Junxuan Zhu, Chengdu (CN); Jun Hou, Chengdu (CN); Dan Luo, Chengdu (CN); and Jingcheng Luo, Chengdu (CN)
Assigned to Sichuan Cancer Hospital, Chengdu (CN)
Filed by Sichuan Cancer Hospital, Chengdu (CN)
Filed on Jun. 27, 2025, as Appl. No. 19/251,906.
Claims priority of application No. 202510337343.5 (CN), filed on Mar. 21, 2025.
Int. Cl. G01N 33/577 (2006.01); C07K 16/28 (2006.01); G01N 33/68 (2006.01)
CPC G01N 33/577 (2013.01) [C07K 16/2803 (2013.01); G01N 33/6872 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); G01N 2333/70503 (2013.01)] 6 Claims
 
1. An anti-CD79B protein monoclonal antibody, comprising a heavy chain and a light chain, wherein the heavy chain includes a heavy chain variable region; the light chain includes a light chain variable region; the heavy chain variable region comprises complementary-determining regions CDR1, CDR2, and CDR3 having amino acid sequences as shown in SEQ ID NO:1, SEQ ID NO:2, and SEQ ID NO:3, respectively; and the light chain variable region comprises complementary-determining regions CDR1, CDR2, and CDR3 having amino acid sequences as shown in SEQ ID NO:9, SEQ ID NO:10, and SEQ ID NO:11, respectively.